Butterfly Network
BFLYPrivate Company
Total funding raised: $1.7B
Overview
Butterfly Network's mission is to make medical imaging universally accessible by fundamentally re-engineering ultrasound technology. The company has achieved this through its proprietary Ultrasound-on-Chip™, which replaces traditional piezoelectric crystals with a semiconductor-based system, enabling a single, affordable handheld probe for whole-body imaging. Its strategy centers on building a comprehensive 'connected medicine' ecosystem that combines the physical device with AI-driven software, workflow tools, and education to drive adoption across clinical specialties and healthcare settings. With a public valuation of approximately $1.05B, Butterfly is a leader in the point-of-care ultrasound (POCUS) market transformation.
Technology Platform
Proprietary Ultrasound-on-Chip™ technology using semiconductor-based Capacitive Micromachined Ultrasonic Transducers (CMUTs) to enable a single, handheld probe for whole-body imaging, replacing traditional piezoelectric crystal systems.
Funding History
8Opportunities
Risk Factors
Competitive Landscape
Butterfly competes with established giants like GE, Philips, and Fujifilm in portable ultrasound, as well as newer handheld rivals. Its primary differentiators are its proprietary Ultrasound-on-Chip™ technology enabling whole-body imaging in one probe, and its integrated ecosystem of hardware, AI software, and education.
Company Timeline
Founded in Burlington, United States
Series C: $250.0M
Series C: $250.0M
IPO — $292.5M